Company Data
Jaguar Health Inc.
Ticker
JAGX
Current Price
$1.29
Market Cap
$11.9M
Price Target
Refer to Report
Volume
127.5K
52wk Range
$0.9501 - $31.74
Overview
Jaguar Health Inc is a commercial stage pharmaceuticals company focused on developing novel, sustainably derived gastrointestinal products. The company’s wholly-owned subsidiary, Napo Pharmaceuticals, Inc focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the marketplace from plants used traditionally in rainforest areas. It operates into two business segments namely Humal health and animal health. Its Mytesi (crofelemer) product is approved by the U.S. FDA for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.